Who owns COLL?
Institutional ownership of Collegium Pharmaceutical Inc. from Form 13F, Q2 2026
279 institutional managers reported holding Collegium Pharmaceutical Inc. (COLL) in Form 13F filings for Q2 2026, with 39,455,970 shares worth $1.4B. The largest reported holder was BlackRock, Inc. Managers that filed both quarters added a net 1,441,482 shares (+4.0%). 44 opened new positions and 30 sold out.
- Funds holding
- 279
- Value held
- $1.4B
- New / sold out
- 44 / 30
- Net shares, same filers
- +4.0%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of COLL
Share of 13F holdings is each fund's shares as a share of the 39,455,970 COLL shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Goldentree Asset Management LP New+$26.9M
- Millennium Management LLC Added+$13.6M
- Principal Financial Group Inc Added+$12.2M
- BlackRock, Inc. Added+$11.1M
- Assenagon Asset Management S.A. Added+$11.0M
- Invesco Ltd. Added+$10.5M
- Pacer Advisors, Inc. New+$10.0M
- First Trust Advisors LP New+$6.3M
- UBS Group AG Added+$5.9M
- Victory Capital Management Inc Added+$4.9M
Biggest sellers in Q2 2026
- Marshall Wace, LLP Trimmed-$17.9M
- Two Sigma Investments, LP Trimmed-$17.5M
- Emerald Advisers, LLC Trimmed-$14.5M
- Emerald Mutual Fund Advisers Trust Sold out-$10.1M
- D. E. Shaw & Co., Inc. Trimmed-$7.0M
- Qube Research & Technologies Ltd Trimmed-$6.9M
- Voloridge Investment Management, LLC Trimmed-$4.2M
- Renaissance Technologies LLC Trimmed-$3.7M
- Hussman Strategic Advisors, Inc. Sold out-$3.5M
- Arrowstreet Capital, Limited Partnership Trimmed-$3.0M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $185M and sold $129M; 118 added and 81 trimmed.
Schedule 13D and 13G filings on COLL
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-11-10STATE STREET CORP SCHEDULE 13G filed by Collegium Pharmaceutical Inc.Schedule 13G
- 2026-08-14FULLER & THALER ASSET MANAGEMENT, INC. SCHEDULE 13G filed by Collegium Pharmaceutical Inc.Schedule 13G
- 2026-08-05PRINCIPAL GLOBAL INVESTORS SCHEDULE 13G filed by Collegium Pharmaceutical Inc.Schedule 13G
- 2026-05-15JANUS HENDERSON GROUP PLC SCHEDULE 13G filed by Janus Henderson Group plcSchedule 13G
- 2026-05-08Invesco Ltd. SCHEDULE 13G filed by Collegium Pharmaceutical Inc.Schedule 13G
- 2025-11-13RENAISSANCE TECHNOLOGIES LLC SCHEDULE 13G filed by Collegium Pharmaceutical Inc.Schedule 13G
- 2025-05-02Pacer Advisors, Inc. SCHEDULE 13G filed by Collegium Pharmaceutical Inc.Schedule 13G
- 2025-02-07Invesco Ltd. SCHEDULE 13G filed by Collegium Pharmaceutical Inc.Schedule 13G
Questions about COLL ownership
- Who owns COLL stock?
- 279 institutional investment managers reported COLL positions in their Form 13F filings for Q2 2026, holding 39,455,970 shares worth $1.4B in total. BlackRock, Inc. reported the largest position.
- Are funds buying or selling COLL?
- In Q2 2026, 44 managers opened new COLL positions, 118 added, 81 trimmed and 30 sold out. Managers that filed in both quarters added a net 1,441,482 shares.
- How current is this COLL institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to COLL by CUSIP. Options are left out. COLL news and filings · COLL insider trades · Top funds